VIRUS OUTBREAK
Covid-19 breath test startup Breathonix raising US$5m capital
Add BT as a preferred source
Singapore
BREATHONIX, a Singapore-based startup which has gotten provisional authorisation locally for its Covid-19 breath test, is raising US$5 million in Series A funding to fuel its growth.
"At this stage now, we are growing very fast. We're expanding our team for commercialisation, so we're actively raising more funds," co-founder and chief operating officer Du Fang said during a Monday virtual press conference.
TRENDING NOW
Japan Home closing outlets; staff say Valu$ taking over operations
How BYD disrupted Singapore’s car market – and why the strategy is turning on itself
From sales executive to DBS chairman: A look at banking veteran Peter Seah’s career
Timah Partners lands S$60 million facility from lenders including UOB, RHB
